Clinical Trial Update: A Two-part Study to Assess the Safety and Preliminary Efficacy of Givinostat in Patients With Polycythemia Vera [Phase 1, Phase 2]

View source ↗

Summary

A two-part Phase 1/2 trial evaluating the safety and preliminary efficacy of givinostat in patients with polycythemia vera has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycythemia Vera

Drugs mentioned

• Givinostat (givinostat)

Snippet

Sponsor: Italfarmaco | Conditions: Polycythemia Vera | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-06-20